SoniVie

ReCor Medical

This medical technology company develops ultrasound renal denervation systems for clinicians treating patients with uncontrolled or resistant hypertension.

SonoThera™

This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.

Aria CV, Inc

This medical technology company develops an implantable balloon system to treat pulmonary arterial hypertension by restoring vessel compliance and reducing cardiac workload.

Sonavex

This medical technology company develops automated ultrasound devices and bioresorbable markers for dialysis clinics and surgical teams to monitor vascular access and blood flow.

Versono

This company develops ultrasonic intravascular devices to treat complex arterial blockages for patients suffering from peripheral vascular disease and critical limb ischaemia.

Alleviant

Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.

Mineralys Therapeutics

The company develops an aldosterone synthase inhibitor medicine to treat patients with uncontrolled or treatment-resistant hypertension and chronic kidney disease.

HistoSonics

HistoSonics develops a non-invasive sonic beam therapy platform for the mechanical destruction of liver and kidney tumours for healthcare providers and physicians.